Profile
BNTX VRTX REGN SGEN ARGX ALNY
Company Name BioNTech SE Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $22.30B $128.84B $64.28B $43.15B $39.39B $33.74B
Employees 6.77K 6.10K 15.16K 3.26K 1.60K 2.23K
CEO Dr. Ugur Sahin M.D. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc. Dr. Yvonne L. Greenstreet M.B.A., M.D.
Ratings
BNTX VRTX REGN SGEN ARGX ALNY
Quant Rating Score 3 2 4 3 3 1
Quant Rating Neutral Sell Buy Neutral Neutral Strong Sell
Trading
BNTX VRTX REGN SGEN ARGX ALNY
Last Close $92.77 $424.99 $527.78 $228.74 $549.65 $251.15
High 52 $126.88 $516.74 $1201.76 $228.74 $671.75 $296.75
Low 52 $78.36 $396.64 $527.78 $228.74 $356.01 $146.93
Price vs. 52 Week High -26.88 % -17.76 % -56.08 % 0 % -18.18 % -15.37 %
Price vs. 52 Week Low 18.39 % 7.15 % 0 % 0 % 54.39 % 70.93 %
Total Return
BNTX VRTX REGN SGEN ARGX ALNY
1 Month Return -0.38 % -10.62 % -3.41 % 0 % 0.63 % 10.99 %
3 Month Return -19.52 % -9.57 % -23.55 % 0 % -14.97 % -8.36 %
6 Month Return -16.15 % -17.76 % -36.29 % 0 % -7.78 % -9.47 %
9 Month Return 14.81 % -9.28 % -53.35 % 0 % 2.74 % -6.82 %
YTD Return -18.59 % 5.54 % -25.91 % 0 % -10.63 % 6.73 %
1 Year Return 1.2 % 0.52 % -45.8 % 0 % 46.72 % 66.91 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BNTX VRTX REGN SGEN ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.15 % - - -
Dividend Paid and Capex Coverage Ration (TTM) 0.54 % -1.65 % 3.85 % -2.27 % -44.32 % -1.49 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
BNTX VRTX REGN SGEN ARGX ALNY
Asset Growth -2.07 % -0.87 % -1.21 %
Gross Profit Growth -31.36 % 10.25 % 22.93 %
Revenue Growth -27.96 % 11.66 % 24.65 %
Revenue 3 Year -85.27 % 45.6 % 91.56 %
Revenue 5 Year 2130.96 % 163.93 % 215.48 %
Revenue 10 Year - 1632.15 % 494.04 %
EBIT Growth -155.7 % -93.69 % 10.13 %
Net Income Growth -171.51 % -114.8 % 9.51 %
Net Income 3 Yeari Growth Per Share -106.57 % -122.89 % -763.59 %
Net Income 5 Yeari Growth Per Share -226.98 % -145.38 % -276.93 %
Net Income 10 Yeari Growth Per Share - 33.84 % -624.16 %
Operating Income Growth -290.37 % -105.41 % 10.13 %
Operating Cash Flow Growth (CFG) -96.13 % -113.93 % 9.07 %
Operating 3 Year CFG -76.28 % -118.65 % -147.99 %
Operating 5 Year CFG 192.12 % -131.3 % -195.86 %
Operating 10 Year CFG - 12.43 % -2622.09 %
EPS Growth -171.58 % -114.8 % 10.81 %
EPS Diluted Growth -172.32 % -114.97 % 10.81 %
Book Value Per Share -3.96 % -6.59 % -9.83 %
Share Holder 3 Year Equity Growth Per Share 65.8 % 62.6 % 33.72 %
Share Holder 5 Year Equity Growth Per Share 3363.7 % 168.85 % 220.81 %
Share Holder 10 Year Equity Growth Per Share - 1265.7 % 691.19 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth 16.02 % 116.42 % -23.28 %
Free Cash Flow Growth -105.24 % -124.1 % 3.67 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2022
Profitability
BNTX VRTX REGN SGEN ARGX ALNY
Gross Profit Margin TTM 80.28 % 86.09 % 84.94 % 72.37 % 46.33 % 86.01 %
Return on Assets TTM -2.99 % -2.38 % 11.98 % -11.76 % 13.45 % -6.4 %
Return on Equity TTM -3.47 % -3.28 % 14.77 % -16.53 % 16.83 % -509.33 %
Return on Capital Employed TTM -5.29 % -1.3 % 11.35 % -16.87 % -0.31 % -3.68 %
Net Income Per EBT TTM 98.26 % -215.53 % 90.27 % 100.55 % 25990.14 % 75.89 %
EBT Per Ebit TTM 64.79 % -100.69 % 129.3 % 94.01 % -18.79 % 308.03 %
EBIT Per Revenue TTM -38.69 % -2.24 % 27.37 % -36.09 % -0.77 % -4.91 %
Cash Flow To Debt Ratio TTM 95.3 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Receivables Turnover TTM 1.8 6.84 2.53 1.98 2.46 5.62
Payables Turnover TTM 1.26 3.71 3.01 1.54 1.83 3.37
Inventory Turnover TTM 1.9 1.27 0.66 0.65 2.93 5.01
Fixed Asset Turnover TTM 231.22 % 425.82 % 300.07 % 256.83 % 5106.8 % 337.41 %
Asset Turnover TTM 12.15 % 48.84 % 37.52 % 34.46 % 35.83 % 55.72 %
Operating Cash Flow Per Share TTM 1.01 -1.91 37.05 -1.12 -1.07 -0.35
Free Cash Flow Per Share TTM -0.87 -3.07 28.3 -1.62 -1.09 -0.58
Cash Per Share TTM 6985.08 % 2375.11 % 7825.12 % 657.5 % 4597.04 % 2024.29 %
Operating Cash Flow Sales Ratio TTM 8.85 % -4.48 % 28.06 % -16.85 % -3.54 % -1.92 %
Free Cash Flow Operating Cash Flow Ratio TTM -86.7 % 160.43 % 76.4 % 144.14 % 102.26 % 167.11 %
Cash Flow Coverage Ratios TTM 95.3 % -28.16 % 146.15 % -185.98 % -201.37 % -3.47 %
Price To Free Cash Flows Ratio TTM -96.26 -163.02 21.29 -141.85 -505.86 -447.57
Price To Operating Cash Flows Ratio TTM 83.42 -261.97 16.35 -203.89 -601.06 -745.64
Price Cash Flow Ratio TTM 83.42 -261.97 16.35 -203.89 -601.06 -745.64
Income Statement (TTM)
BNTX VRTX REGN SGEN ARGX ALNY
Revenue $2.75B $11.02B $14.2B $1.96B $2.19B $2.25B
Gross Profit $2.21B $9.49B $12.23B $1.55B $1.96B $1.92B
Gross Profit Ratio 80.32% 86.11% 86.13% 79.1% 89.62% 85.62%
EBITDA $-0.37B $0.48B $5.32B $-0.62B $0B $-0.18B
Net Income $-0.67B $-0.54B $4.41B $-0.61B $0.83B $-0.28B
EPS Diluted -2.77 -2.08 38.34 -3.3 12.78 -2.16
Balance Sheet (MRQ)
BNTX VRTX REGN SGEN ARGX ALNY
Long Term Debt $0.21B $1.66B $1.98B $0.04B $0.03B $0B
Total Liabilities $3.12B $6.12B $8.41B $0.87B $0.7B $4.17B
Total Equity $19.41B $16.41B $29.35B $2.8B $5.5B $0.07B
Total Investments $8.28B $6.65B $15.42B $1.42B $1.93B $1.73B
Total Debt $0.25B $1.75B $2.7B $0.04B $0.04B $1.3B
Total Assets $22.53B $22.53B $37.76B $3.67B $6.2B $4.3B
Cash Flow Statement (TTM)
BNTX VRTX REGN SGEN ARGX ALNY
Net Income $-0.68B $-0.54B $4.41B $-0.61B $0.8B $-0.28B
Inventory $0.07B $-0.52B $-0.62B $-0.23B $-0.09B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $0.21B $-0.49B $4.42B $-0.45B $-0.08B $-0.01B
Capital Expenditure $-0.45B $-0.3B $-0.76B $-0.08B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24.31
ABCL AbCellera Biologics Inc. 2.03
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.27
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 0.9801
ABPWW 0.02
ABSI Absci Corporation 2.75
ABUS Arbutus Biopharma Corporation 3.23
ABVC ABVC BioPharma, Inc. 1.21
ABVX Abivax SA American Depositary Shares 6.71
ACAD ACADIA Pharmaceuticals Inc. 17.44
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6099
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.35
ACIU AC Immune SA 1.68
ACLX Arcellx, Inc. 57.55
ETFs With Exposure to BNTX
Ticker ETF Name Weight Percentage Price
IBB iShares Biotechnology ETF 1.88145 116.63
SPDW SPDR Portfolio Developed World ex-US ETF 0.031271 38.43
FBT First Trust NYSE Arca Biotechnology Index Fund 3.39 152.78
BIB ProShares Ultra Nasdaq Biotechnology 0.329589 39.63
BBH VanEck Biotech ETF 2.71 140.05
FNDF Schwab Fundamental International Large Company Index ETF 0.138992 37.76
ONEQ Fidelity Nasdaq Composite Index ETF 0.04 70.57
IDHQ Invesco S&P International Developed Quality ETF 0.136 31.46
PXF Invesco FTSE RAFI Developed Markets ex-U.S. ETF 0.03 54.33
DMRI DeltaShares S&P International Managed Risk ETF 0.01 46.68
FPXI First Trust International Equity Opportunities ETF 1.21 50.95
FPXE First Trust IPOX Europe Equity Opportunities ETF 1.01 28.02
GNOM Global X Genomics & Biotechnology ETF 4.86 7.5035
IUS Invesco RAFI Strategic US ETF 0.153 48.5
VETS Pacer Military Times Best Employers ETF 0.95 38.62
VHCOX Vanguard Capital Opportunity Fund Investor Shares 0.92 78.75
VHCAX Vanguard Capital Opportunity Fund 1.15 181.74
KOMP SPDR S&P Kensho New Economies Composite ETF 0.022714 48.79
IDNA iShares Genomics Immunology and Healthcare ETF 3.91352 19.16
PTIN Pacer Trendpilot International ETF 0.05 27.32
VALT ETFMG Sit Ultra Short ETF 7.09 48.52
ZDEU SPDR Solactive Germany ETF 1.95 67.24
SLT Pacer Salt High truBeta US Market ETF 0.95 39.22
LSLT Pacer Salt Low truBeta US Market ETF 0.95 32
HELX Franklin Genomic Advancements ETF 2.71 26.07
NIFE Direxion Fallen Knives ETF 3.19764 45.1958
GERM ETFMG Treatments, Testing and Advancements ETF 5.01 19.1577
CEFA Global X S&P Catholic Values Developed ex-U.S. ETF 0.32 33.1804
VIRS Pacer BioThreat Strategy ETF 0.95 40.025
BMED BlackRock Future Health ETF 0.15634 23.6
QQQJ Invesco NASDAQ Next Gen 100 ETF 0.621 29.61
QQQN VictoryShares Nasdaq Next 50 ETF 1.03759 31.65
FXDE.ME FinEx Funds Public Limited Company - FinEx Germany UCITS ETF 0.92 26.7
SILX ETFMG Prime 2x Daily Junior Silver Miners ETF 6.05 1.75
IBBQ Invesco Nasdaq Biotechnology ETF 1.087 19.47
2B70.DE iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 1.15357 5.111
RTL The Necessity Retail REIT, Inc. 1.26 7.61
BAD B.A.D. ETF 1.29 11.91
IFSW.L iShares Edge MSCI World Multifactor UCITS ETF USD (Acc) 0.08605 11.6375
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 1.08442 5.75
FTQI First Trust Nasdaq BuyWrite Income ETF 0.16 18.91
MSGR Direxion mRNA ETF 5.75767 13.9102
WDNA WisdomTree BioRevolution Fund 0.0116278 12.1
DMCY Democracy International Fund 0.0003 26.8939
QQJG Invesco ESG NASDAQ Next Gen 100 ETF 0.495 22.54
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF 1.08442 5.743
IS07.DE iShares Edge MSCI World Multifactor UCITS ETF 0.08605 8.874
IFSD.L iShares Edge MSCI Europe Multifactor UCITS ETF 0.09275 7.17
FSEU.L iShares Edge MSCI Europe Multifactor UCITS ETF EUR (Acc) 0.09275 869.95
IDNA.L iShares MSCI North America UCITS ETF 3.61079 104.985
TYNE Direxion Nanotechnology ETF 1.54396 17.2638
TRPL Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF 0.95 41.14
GLOF iShares Trust - iShares Global Equity Factor ETF 0.06934 44.255
APXH Two Roads Shared Trust - APEX HealthCare ETF 4.08 8.87
TCAF T. Rowe Price Exchange-Traded Funds, Inc. - T. Rowe Price Capital Appreciation Equity ETF 0.193112 32.43
WDMF.AX iShares Edge MSCI World Multifactor ETF 0.07704 46.96
CANC Tema Oncology ETF 1.09 23.25
Unlock